1,3-diamino-2-methylimidazolium chloride | 111132-20-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,3-diamino-2-methylimidazolium chloride
• 英文别名: 2-methylimidazol-1-ium-1,3-diamine;chloride
• CAS: 111132-20-8
• 化学式: C₄H₉N₄*Cl
• 分子量: 148.595
• InChiKey: FXIGRRCERPPQCK-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -4.48
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  60.8
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-dimethylamino-3,5-dimethoxy-benzaldehyde 、 1,3-diamino-2-methylimidazolium chloride 以 溶剂黄146 、 乙酸乙酯 为溶剂， 生成 1,3-bis[[4-(dimethylamino)-3,5-dimethoxybenzylidene]amino]-2-methylimidazolium chloride
  参考文献：
  名称：

  Antimicrobial imidazolium derivatives

  摘要：

  具有以下结构的化合物##STR1##，其中各种取代基在下文中定义，并且其药用可接受的酸盐具有药理学性质。特别地，它们具有抗菌、抗真菌、原虫杀灭和/或驱虫性能。

  公开号：

  US04831151A1

文献信息

• Antimicrobial 1,3-disubstituted/imidazolium salts
  申请人：Hoffman-La Roche Inc.

  公开号：US04814332A1

  公开（公告）日：1989-03-21

  The imidazolium compounds of the formula ##STR1## wherein the various substituents are defined hereinbelow and their pharmaceutically acceptable acid addition salts, which possess valuable pharmacological properties are described. In particular, they possess antibacterial, antimycotic, protozoacidal and/or anthelmintic properties and are especially active against parasitic protozoa and worms. The compounds of formula I can be prepared according to known methods.

  本文描述了具有有价值的药理特性的公式##STR1##的咪唑化合物，其中各种取代基在下文中定义，并其药学上可接受的酸盐。特别是，它们具有抗菌、抗真菌、原虫杀灭和/或驱虫特性，对寄生原虫和蠕虫特别活跃。公式I的化合物可以按照已知方法制备。
• Hydrogen Bonding in the Crystal Structures of New Imidazolium Triflimide Protic Ionic Liquids
  作者：Gino Bentivoglio、Alexander Schwärzler、Klaus Wurst、Volker Kahlenberg、Gerhard Nauer、Günther Bonn、Herwig Schottenberger、Gerhard Laus

  DOI：10.1007/s10870-009-9554-8

  日期：2009.9

  The synthesis and crystal structures of 1,3-diamino-2-methylimidazolium bis(trifluoromethylsulfonyl)imide (1), 1,3-dihydroxy-2-methylimidazolium bis(trifluoromethylsulfonyl)imide (2) and 1-(2-(diethylammonio)ethyl)-3-methylimidazolium bis(bis(trifluoromethylsulfonyl)imide) (4) are reported. The salts 1, 2 and 4 have melting points below 100 °C, the intermediate 1-(2-(diethylamino)ethyl)-3-methylimidazolium bis(trifluoromethylsulfonyl)imide (3) is liquid at room temperature. Compound 1 is monoclinic, space group P21/n with a = 8.4979(4) Å, b = 12.2803(6) Å, c = 13.9400(7) Å, β = 93.086(4)°, and Z = 4. Compound 2 is monoclinic, space group P21/c with a = 7.6165(2) Å, b = 20.5323(8) Å, c = 9.7654(3) Å, β = 111.046(2)°, and Z = 4. Compound 4 is triclinic, space group $$ P\overline1} $$ with a = 8.5313(4) Å, b = 9.2157(4) Å, c = 20.5812(8) Å, α = 84.668(2)°, β = 83.738(2)°, γ = 63.096(2)°, and Z = 2. The ions in 1 build a network of N–H···O hydrogen bonds, in 2 they are linked to chains by O–H···N and bifurcated O–H···O hydrogen bonds, whereas in 4 they form pairs by N–H···O contacts. The triflimide anions adopt transoid conformations. Short interionic contacts, conformational flexibility, and disorder phenomena were identified in the crystal structures of three new, low-melting, protic imidazolium triflimides.

  报道了1,3-二氨基-2-甲基咪唑鎓双（三氟甲基磺酰）亚胺（1）、1,3-二羟基-2-甲基咪唑鎓双（三氟甲基磺酰）亚胺（2）和1-（2-（二乙氨基）乙基）-3-甲基咪唑鎓双（双（三氟甲基磺酰）亚胺）（4）的合成及其晶体结构。盐1、2和4的熔点均低于100°C，中间体1-（2-（二乙氨基）乙基）-3-甲基咪唑鎓双（三氟甲基磺酰）亚胺（3）在室温下为液体。化合物1为单斜晶系，空间组P21/n，a = 8.4979(4) Å，b = 12.2803(6) Å，c = 13.9400(7) Å，β = 93.086(4)°，Z = 4。化合物2为单斜晶系，空间组P21/c，a = 7.6165(2) Å，b = 20.5323(8) Å，c = 9.7654(3) Å，β = 111.046(2)°，Z = 4。化合物4为三斜晶系，空间组$$ P\overline1} $$，a = 8.5313(4) Å，b = 9.2157(4) Å，c = 20.5812(8) Å，α = 84.668(2)°，β = 83.738(2)°，γ = 63.096(2)°，Z = 2。化合物1中的离子形成N–H···O氢键网络，在化合物2中，离子通过O–H···N和分叉的O–H···O氢键连接成链，而在化合物4中则通过N–H···O接触形成对。三氟磺酰亚胺阴离子采用反式构象。在这三种新的低熔点质子性咪唑鎓三氟磺酰亚胺的晶体结构中，识别出了短离子间接触、构象灵活性和无序现象。
• Imidazolium hydrogen carbonates
  申请人：Hoffmann-LaRoche Inc.

  公开号：US04808727A1

  公开（公告）日：1989-02-28

  The pharmaceutically acceptable salts corresponding to the imidazolium hydrogen carbonates of the formula ##STR1## wherein the symbol Q is arylene or heteroarylene, the group --NR.sup.1 R.sup.2 is a basic amino group, R.sup.3 is hydrogen, lower alkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower haloalkyl, lower alkylthio, lower alkoxy or the group --(A).sub.n --Ra, R.sup.4 is a saturated or partially unsaturated lower hydrocarbon group, a basic amino group or the group --N.dbd.CRc--Rb, --CHRcRd, --NH--CHRcRd, --NH--CO--Re or --CHRc--CO--Re, R.sup.5 is hydrogen, lower alkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower haloalkyl, aryl or a fused benzene ring, R.sup.6 is hydrogen or lower alkyl, Ra and Rb each is aryl, heteroaryl or a basic amino group, Rc is hydrogen or lower alkyl, Rd is aryl or heteroaryl, Re is hydrogen, a saturated or partially unsaturated lower hydrocarbon group optionally attached via an oxygen atom or an aryl, heteroaryl or basic amino group optionally attached via a lower alkyl group, A is vinylene or lower alkylene, n is the integer 0 or 1 and the dotted line is an additional double bond, possess valuable antibacterial, antimycotic, protozoocidal and/or anthelmintic properties. The imidazolium bicarbonates of formula I can be used to prepare such pharmaceutically acceptable, especially water-soluble, salts in a simple and inexpensive manner.

  对应于以下公式的咪唑氢碳酸盐，其符合药用标准：其中符号Q是芳基或杂芳基，基团--NR.sup.1R.sup.2是碱性氨基，R.sup.3是氢、低烷基、低羟基烷基、低烷氧基烷基、低卤代烷基、低烷硫基、低烷氧基或基团--(A).sub.n--Ra，R.sup.4是饱和或部分不饱和的低碳氢基团、碱性氨基团或基团--N.dbd.CRc--Rb，--CHRcRd，--NH--CHRcRd，--NH--CO--Re或--CHRc--CO--Re，R.sup.5是氢、低烷基、低羟基烷基、低烷氧基烷基、低卤代烷基、芳基或融合苯环，R.sup.6是氢或低烷基，Ra和Rb分别是芳基、杂芳基或碱性氨基，Rc是氢或低烷基，Rd是芳基或杂芳基，Re是氢、饱和或部分不饱和的低碳氢基团，可选地通过氧原子或芳基、杂芳基或碱性氨基通过低烷基团连接，A是乙烯基或低烷基，n是整数0或1，虚线是额外的双键，具有有价值的抗菌、抗真菌、原虫毒和/或驱虫性质。公式I的咪唑碳酸氢盐可用于以简单和廉价的方式制备这种药用标准，特别是水溶性盐。
• 1,3-disubstituted/imidazolium salts
  申请人：Hoffmann-La Roche Inc.

  公开号：US04956470A1

  公开（公告）日：1990-09-11

  The imidazolium compounds of the formula ##STR1## wherein Q is arylene or heteroarylene, the group --NR.sup.1 R.sup.2 is a basic amino group, R.sup.3 is lower alkylthio, lower alkoxy or the group --(A).sub.n --Ra, R.sup.4 is a saturated or partially unsaturated lower hydrocarbon group, a basic amino group, --N.dbd.CRc--Rb, --CHRcRd, --NH--CHRcRd, --NH--CO--Re or --CHRc--CO--Re, R.sup.5 is hydrogen, lower alkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower haloalkyl, aryl or a fused benzene ring, R.sup.6 is hydrogen or lower alkyl, Ra and Rb independently are aryl, heteroaryl or a basic amino group, Rc is hydrogen or lower alkyl, Rd is aryl or heteroaryl, Re is hydrogen, a saturated or partially unsaturated lower hydrocarbon group optionally attached via an oxygen atom, or an aryl, heteroaryl or basic amino group optionally attached via a lower alkyl group, A is vinylene or lower alkylene, n is the integer 0 or 1, the dotted line is an additional double bond and the symbol Y.sup.- is a pharmaceutically acceptable anion, and their pharmaceutically acceptable acid addition salts, which possess valuable pharmacological properties are described. In particular, they possess antibacterial, antimycotic, protozoacidal and/or anthelmintic properties and are especially active against parasitic protozoa and worms. The compounds of formula I can be prepared according to known methods.

  本文描述了式为##STR1##的咪唑化合物，其中Q为芳基或杂芳基，--NR.sup.1 R.sup.2为碱性氨基，R.sup.3为较低的烷基硫醚，较低的烷氧基或--(A).sub.n --Ra，R.sup.4为饱和或部分不饱和的较低碳氢基团，碱性氨基，--N.dbd.CRc--Rb，--CHRcRd，--NH--CHRcRd，--NH--CO--Re或--CHRc--CO--Re，R.sup.5为氢，较低的烷基，较低的羟基烷基，较低的烷氧基烷基，较低的卤代烷基，芳基或融合苯环，R.sup.6为氢或较低的烷基，Ra和Rb分别为芳基，杂芳基或碱性氨基，Rc为氢或较低的烷基，Rd为芳基或杂芳基，Re为氢，饱和或部分不饱和的较低碳氢基团，可选通过氧原子连接，或芳基，杂芳基或碱性氨基可选通过较低的烷基连接，A为乙烯基或较低的烷基烯，n为整数0或1，点线为额外的双键，符号Y.sup.-为药学上可接受的阴离子，以及它们的药学上可接受的酸加盐，具有有价值的药理学特性。特别是，它们具有抗菌，抗真菌，抗原虫和/或驱虫特性，特别是对寄生原虫和蠕虫特别活跃。式I的化合物可以按照已知方法制备。